KPV, GHK-CU, BPC-157, TB-500 (Klow)

FDA APPROVAL PENDING

KPV, GHK-CU, BPC-157, TB-500 (Klow)

Four-Peptide Regenerative Blend

Learn more

Weight

KPV, GHK-CU, BPC-157, TB-500 (Klow)

Metabolic

Amino acid sequence

18

Amino acids

0da

Molecular weight

Blend

Type

KLOW builds upon GLOW protocol by adding KPV for enhanced anti-inflammatory action. This combination lacks clinical trials on the specific four-peptide formulation despite individual component research. Standard vial contains 80mg blend (50mg GHK-Cu, 10mg TB-500, 10mg BPC-157, 10mg KPV).

Top researched benefits

Overview of KPV, GHK-CU, BPC-157, TB-500 (Klow)

Each peptide contributes distinct biological pathways: GHK-Cu modulates gene expression for tissue repair, TB-500 enhances cellular migration and wound healing, BPC-157 upregulates growth factors for tissue regeneration, and KPV inhibits NF-κB inflammatory pathway.

primary applications

  • Multi-modal healing addressing tissue through complementary pathways
  • Enhanced tolerability with KPV versus GLOW formulation
  • Single injection convenience factor
  • Collagen stimulation and tissue regeneration

Typical Dose

200-500 mcg total blend daily

Frequency

Once daily for consistent tissue repair support

Cycle Duration

4-6 weeks

Storage

Lyophilized: Room temperature. Reconstituted: 2-8°C, use within 4-6 weeks

Chemical Makeup

Key benefits

Theoretical synergistic multi-pathway tissue repair

Anti-inflammatory effects across multiple mechanisms

Cellular regeneration support

Convenience of single injection dosing

KPV may reduce injection site reactions versus GLOW

Community interest

This peptide is still gaining traction in the community.

Four-Peptide Regenerative Blend

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes
No

KPV, GHK-CU, BPC-157, TB-500 (Klow) Molecular Information

View the scientifc details of KPV, GHK-CU, BPC-157, TB-500 (Klow).

18

Amino Acids

KPV, GHK-CU, BPC-157, TB-500 (Klow)

Gly

Gly

Position 1

His

His

Position 2

Lys

Lys

Position 3

Cys

Cys

Position 4

Sec

Sec

Position 5

Thr

Thr

Position 6

Asx

Asx

Position 7

Asx

Asx

Position 8

Pro

Pro

Position 9

Cys

Cys

Position 10

Lys

Lys

Position 11

Pro

Pro

Position 12

Val

Val

Position 13

Arg

Arg

Position 14

Ala

Ala

Position 15

Thr

Thr

Position 16

Ile

Ile

Position 17

Pyl

Pyl

Position 18

Amino acid sequence
GlycinePosition 1
HistidinePosition 2
LysinePosition 3
CysteinePosition 4
SelenocysteinePosition 5
ThreoninePosition 6
Aspartic acid or AsparaginePosition 7
Aspartic acid or AsparaginePosition 8
ProlinePosition 9
CysteinePosition 10
LysinePosition 11
ProlinePosition 12
ValinePosition 13
ArgininePosition 14
AlaninePosition 15
ThreoninePosition 16
IsoleucinePosition 17
PyrrolysinePosition 18

Molecular Weight

0Da

Chain Length

18Amino Acids

Type

Blend

KPV, GHK-CU, BPC-157, TB-500 (Klow) Protocols

Subcutaneous injection with rotation between abdomen, thighs, and upper arms.

GoalDosageFrequencyRoute
Conservative approach2001 week rangeSubcutaneous
Standard research protocol2001 week rangeSubcutaneous
Cycling protocol4 week rangeSubcutaneous

Reconstitution Instructions

Materials needed:

KLOW 80mg vialBacteriostatic water (2-5mL)Insulin syringesAlcohol prep pads

Steps to reconstitute

  1. Clean vial top with alcohol pad
  2. Add 4mL bacteriostatic water (creates 20mg/mL)
  3. Gently swirl - do not shake
  4. Solution should appear clear to slightly cloudy
  5. Label with date and concentration
  6. Store refrigerated immediately
  7. Use within 4-6 weeks

KPV, GHK-CU, BPC-157, TB-500 (Klow) Cycle

The KPV, GHK-CU, BPC-157, TB-500 (Klow) Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Day 1-7
Some users report inflammation reduction within days
Week 2-4
Wound healing effects may develop if they manifest
Week 4-6
Full cycle effects; assess response
Week 0-0
2-4 weeks off between cycles recommended

Dosing tools

KPV, GHK-CU, BPC-157, TB-500 (Klow)Blend Dosage Calculator

Calculate blended peptide doses with our visual syringe guide.

Volume of bacteriostatic water you add to reconstitute the powder. Use BAC water for preservation.

1 mL

2 mL

3 mL

5 mL

Custom

Custom Blend Compounds

Total: 80.0 mg

mg

mg

mg

mg

The dose of the anchor peptide you want per administration, in mcg or mg.

Conversion: 1,000 mcg = 1 mg

Results

Concentration

80.00

mg/mL

Doses per vial

40

Total blend to inject

2.00

mg

You'll get:

BPC-157
250 mcgANCHOR
GHK-Cu
1.25 mg
KPV
250 mcg
TB-500
250 mcg

1mL / 100 units

2 units

0.025 mL

Dosing Guidance

Recommended Schedule

Once daily for consistent tissue repair support

Supply Duration

This vial provides 40 doses (40-day supply at 250 mcg daily)

Peptide Interactions

Research suggestions of KPV, GHK-CU, BPC-157, TB-500 (Klow) interactions with other common peptides and substances.

Weight

ipa

Growth

Ipamorelin

COMPATIBLE

No studies on combination; theoretical compatibility based on different mechanisms

COMPATIBLE

Longevity

nad

Metabolic

NAD+

COMPATIBLE

No data combining KLOW with NAD+; both affect cellular processes differently

COMPATIBLE

Side effects

Contraindications

No safety studies on four-peptide combination

Long-term effects completely unknown

FDA has not approved any component for therapeutic use

Stop signs

Severe injection site reactions or infection

Allergic reactions (rash, difficulty breathing)

Unusual fatigue or weakness

Signs of copper toxicity (nausea, jaundice)

Worsening of underlying conditions

Bad signs

Vendors without Certificate of AnalysisSuspiciously low prices suggest counterfeits
Was it helpful?Yes
No

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What is a peptide dosage calculator?

A peptide dosage calculator is a free tool that converts your vial size, bacteriostatic water volume, and target dose into an exact syringe draw volume. Instead of doing the reconstitution math by hand, you enter three inputs and instantly get the concentration of your solution and how many milliliters or syringeunits to draw. This calculator works for single peptide compounds and multi-peptide blends.

How do I calculate peptide dosage from a vial?

To calculate your peptide dose, divide the total peptide content of your vial in micrograms by the volume of bacteriostatic water you added in milliliters. This gives you your solution concentration in mcg/mL. Then divide your target dose by that concentration to get your draw volume. For example, a 5mg (5,000 mcg) vial reconstituted with 2mL of BAC water gives a concentration of 2,500 mcg/mL. A 250 mcg dose would require drawing 0.1mL. This calculator automates all of those steps instantly.

How much Bacteriostatic water should I add to a peptide vial?

Most people add 2mL to 3mL of bacteriostatic water per vial, but the right amount depends on the dose you want to draw and the syringe size you are using. Adding 1mL to a 5mg vial gives you a concentration of 5,000 mcg/mL, making each dose very small in volume. Adding 2mL gives you 2,500 mcg/mL, which is easier to measure on a standard insulin syringe. A general guideline is to choose a volume that puts your typical dose somewhere between 10 and 30 units on a U-100 syringe. Use the calculator above to test different water volumes and find what works for your dose.

How are peptides different from proteins?

Both are made of amino acids, but peptides are much smaller than proteins. Because of their tiny size, peptides can act like tiny messengers in the body, sending specific signals to your cells to tell them exactly what to do.​

KPV, GHK-CU, BPC-157, TB-500 (Klow)Research References

KPV, GHK-CU, BPC-157, TB-500 (Klow) is a limited research compound

3Research references

KPV, GHK-CU, BPC-157, TB-500 (Klow)

KPV, GHK-CU, BPC-157, TB-500 (Klow) is a limited research compound

Individual Component Research—GHK-Cu

GHK-Cu demonstrates wound healing, anti-aging, and gene modulation effects in isolation

n.d.

BPC-157 Limited Human Data

Small pilot showed 10 of 12 patients achieved complete symptom resolution in interstitial cystitis

n.d.

No Published Studies on KLOW Combination

Scientific studies examining safety or efficacy of the four-peptide KLOW combination do not exist

n.d.